Mostrar el registro sencillo del ítem

dc.contributor.author
Basquiera, Ana Lisa  
dc.contributor.author
Odstrcil Bobillo, María Silvina  
dc.contributor.author
Peroni, María Leticia  
dc.contributor.author
Sanchez Thomas, Diego  
dc.contributor.author
Vitriu, Adriana  
dc.contributor.author
Berro, Mariano  
dc.contributor.author
Rosales Ostriz, Belen  
dc.contributor.author
Milovic, Vera  
dc.contributor.author
Martinez Rolón, Juliana  
dc.contributor.author
Jaimovich, Gregorio  
dc.contributor.author
Hansen Krogh, Daniela  
dc.contributor.author
Tagliafichi, Viviana  
dc.contributor.author
Bisigniano, Liliana  
dc.contributor.author
Arbelbide, Jorge Alberto  
dc.contributor.author
Giunta, Diego Hernan  
dc.date.available
2023-12-14T13:44:17Z  
dc.date.issued
2023-04  
dc.identifier.citation
Basquiera, Ana Lisa; Odstrcil Bobillo, María Silvina; Peroni, María Leticia; Sanchez Thomas, Diego; Vitriu, Adriana; et al.; Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI; Elsevier; Hematology, Transfusion and Cell Therapy; 45; 2; 4-2023; 224-234  
dc.identifier.issn
2531-1379  
dc.identifier.uri
http://hdl.handle.net/11336/220339  
dc.description.abstract
Introduction: Hematopoietic stem cell transplantation is the only curative treatment for many disorders and international data shows a growing trend. Method: We aimed to evaluate the temporal trends in HSCT transplant rates in Argentina. A time-series analysis was performed for the period 2009 to 2018 using the national database from the National Central Coordinating Institute for Ablations and Implants. Crude and standardized transplant rates were calculated. A permutation joinpoint regression model analysis was used to identify significant changes over time. Results: Altogether, 8,474 transplants were reported to INCUCAI by 28 centers (autologous 67.5%); the main indication was multiple myeloma (30%). The WHO age-sex standardized HSCT rates for the entire country were 153.3 HSCT/10 million inhabitants (95% CI 141.7–165.8) in 2009 and 260.1 HSCT/10 million inhabitants (95% CI 245.5–275.5) in 2018. There was a large gap in HSCT rates among the states and regions. The transplant rate was higher for autologous transplants throughout the years. Within the allogeneic group, the related donor transplant rate was higher than the unrelated donor transplant rate. The joinpoint regression analysis of HSCT rates for the whole country over time showed an observed annual percentage change of 6.3% (95% CI 5.4-7.3; p < 0.01). No changes were observed for unrelated donors during the study period. Conclusions: Age-sex standardized HSCT rates in Argentina are increasing, mainly due to autologous and family donor allogeneic transplants. A wide variation across the country was found, demonstrating differences in the access to transplantation among Argentine regions.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
ALLOGENEIC  
dc.subject
ARGENTINA  
dc.subject
AUTOLOGOUS  
dc.subject
EPIDEMIOLOGIC STUDIES  
dc.subject
STEM CELL TRANSPLANTATION  
dc.subject.classification
Trasplantes  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2023-12-12T13:07:54Z  
dc.identifier.eissn
2531-1387  
dc.journal.volume
45  
dc.journal.number
2  
dc.journal.pagination
224-234  
dc.journal.pais
Brasil  
dc.description.fil
Fil: Basquiera, Ana Lisa. Hospital Italiano; Argentina. Hospital Privado Universitario de Córdoba; Argentina  
dc.description.fil
Fil: Odstrcil Bobillo, María Silvina. Hospital Italiano; Argentina  
dc.description.fil
Fil: Peroni, María Leticia. Hospital Italiano; Argentina  
dc.description.fil
Fil: Sanchez Thomas, Diego. Hospital Italiano; Argentina  
dc.description.fil
Fil: Vitriu, Adriana. Instituto Alexander Fleming; Argentina  
dc.description.fil
Fil: Berro, Mariano. Universidad Austral; Argentina  
dc.description.fil
Fil: Rosales Ostriz, Belen. Hospital de Clínicas José de San Martínbuenos Aires; Argentina  
dc.description.fil
Fil: Milovic, Vera. Hospital Aleman; Argentina  
dc.description.fil
Fil: Martinez Rolón, Juliana. Fundación Para Combatir la Leucemia; Argentina  
dc.description.fil
Fil: Jaimovich, Gregorio. Fundación Favaloro; Argentina  
dc.description.fil
Fil: Hansen Krogh, Daniela. Secretaria de Gobierno de Salud. Instituto Nacional Central Único Coordinador de Ablación e Implante; Argentina  
dc.description.fil
Fil: Tagliafichi, Viviana. Secretaria de Gobierno de Salud. Instituto Nacional Central Único Coordinador de Ablación e Implante; Argentina  
dc.description.fil
Fil: Bisigniano, Liliana. Secretaria de Gobierno de Salud. Instituto Nacional Central Único Coordinador de Ablación e Implante; Argentina  
dc.description.fil
Fil: Arbelbide, Jorge Alberto. Secretaria de Gobierno de Salud. Instituto Nacional Central Único Coordinador de Ablación e Implante; Argentina  
dc.description.fil
Fil: Giunta, Diego Hernan. Hospital Italiano; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.journal.title
Hematology, Transfusion and Cell Therapy  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2531137922000451  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.htct.2022.02.008